Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature. [electronic resource]
Producer: 20160114Description: S46-53 p. digitalISSN:- 0392-856X
- Adolescent
- Adult
- Amyloidosis -- blood
- Anti-Inflammatory Agents -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Biomarkers -- blood
- Child
- Chronic Disease
- Databases, Factual
- Down-Regulation
- Female
- Humans
- Immunocompromised Host
- Inflammation -- blood
- Interleukin-6 -- antagonists & inhibitors
- Male
- Middle Aged
- Opportunistic Infections -- chemically induced
- Quality of Life
- Receptors, Interleukin-6 -- antagonists & inhibitors
- Remission Induction
- Risk Factors
- Serum Amyloid A Protein -- metabolism
- Signal Transduction -- drug effects
- Surveys and Questionnaires
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.